Related topics

Regulus: Q1 Earnings Snapshot

May 12, 2022 GMT

SAN DIEGO (AP) _ Regulus Therapeutics Inc. (RGLS) on Thursday reported a loss of $6.7 million in its first quarter.

The San Diego-based company said it had a loss of 5 cents per share.


This story was generated by Automated Insights ( using data from Zacks Investment Research. Access a Zacks stock report on RGLS at